Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways.
ER membrane domains
HPLC
immunology
inflammation
leukotrienes
lipid mass spectrometry
peritoneal-derived mast cells
signal transduction
sphingolipids
Journal
Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606
Informations de publication
Date de publication:
2021
2021
Historique:
received:
17
06
2021
revised:
23
08
2021
accepted:
08
09
2021
pubmed:
25
9
2021
medline:
25
3
2022
entrez:
24
9
2021
Statut:
ppublish
Résumé
Leukotrienes (LTs) and sphingolipids are critical lipid mediators participating in numerous cellular signal transduction events and developing various disorders, such as bronchial hyperactivity leading to asthma. Enzymatic reactions initiating production of these lipid mediators involve 5-lipoxygenase (5-LO)-mediated conversion of arachidonic acid to LTs and serine palmitoyltransferase (SPT)-mediated de novo synthesis of sphingolipids. Previous studies have shown that endoplasmic reticulum membrane protein ORM1-like protein 3 (ORMDL3) inhibits the activity of SPT and subsequent sphingolipid synthesis. However, the role of ORMDL3 in the synthesis of LTs is not known. In this study, we used peritoneal-derived mast cells isolated from ORMDL3 KO or control mice and examined their calcium mobilization, degranulation, NF-κB inhibitor-α phosphorylation, and TNF-α production. We found that peritoneal-derived mast cells with ORMDL3 KO exhibited increased responsiveness to antigen. Detailed lipid analysis showed that compared with WT cells, ORMDL3-deficient cells exhibited not only enhanced production of sphingolipids but also of LT signaling mediators LTB
Identifiants
pubmed: 34560079
pii: S0022-2275(21)00103-6
doi: 10.1016/j.jlr.2021.100121
pmc: PMC8527048
pii:
doi:
Substances chimiques
Eicosanoids
0
Membrane Proteins
0
ORMDL3 protein, mouse
0
Sphingolipids
0
Arachidonate 5-Lipoxygenase
EC 1.13.11.34
Serine C-Palmitoyltransferase
EC 2.3.1.50
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100121Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.